TIGER 글로벌비만치료제TOP2Plus (476690) holdings & weights
Per-holding contribution · concentration · sector skew — a deep read
Fund overview
This is a Korea-listed ETF from 미래에셋자산운용.
Fund details
Fund overview
This is a Korea-listed ETF from 미래에셋자산운용.
10 identified stocks · net exposure / NAV 100.08%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.
Weight and calculation basis
10 identified stocks · net exposure / NAV 100.08%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.
Investor flows
We have this ETF's holdings, but the prices for those particular listings are outside our quote coverage (currently Korea- and US-listed securities). So today's contribution and return are not computed — showing 0% would claim it did not move, which is a different statement. The holdings and weights below follow the calculation basis above.
Today's summary
Its top 10 holdings make up about 100.0% of the fund. The concentration index (HHI) is 1577 — Moderate, and the largest sector is Health Care (92%). The higher the concentration, the more one stock or sector drives the whole ETF's return.
Structural health
A five-axis read on how this fund is built. It is not a return forecast or a recommendation, and a low score does not mean a bad fund — leveraged products score low by design. Each axis shows the figure behind it.
Concentration sits in the 1,500–2,500 band (1,577) — moderate.
Health Care alone is 92%. This is effectively a bet on that one industry — if the sector falls, diversification will not help.
A plain 1x physical fund holding the shares themselves — no structural drift from how long you hold it.
We don't have cost, fund size for TIGER 글로벌비만치료제TOP2Plus yet, so those axes are excluded and the score is based on the other 3. Scoring a missing figure as zero would grade our data collection, not the fund.
Concentration and diversification
Structural health
A five-axis read on how this fund is built. It is not a return forecast or a recommendation, and a low score does not mean a bad fund — leveraged products score low by design. Each axis shows the figure behind it.
Concentration sits in the 1,500–2,500 band (1,577) — moderate.
Health Care alone is 92%. This is effectively a bet on that one industry — if the sector falls, diversification will not help.
A plain 1x physical fund holding the shares themselves — no structural drift from how long you hold it.
We don't have cost, fund size for TIGER 글로벌비만치료제TOP2Plus yet, so those axes are excluded and the score is based on the other 3. Scoring a missing figure as zero would grade our data collection, not the fund.
Top 10 holdings
Weights are normalized to 100% of absolute exposures across analysed positions, including positions outside this top list. Cash, collateral and unverified assets are excluded. Contributions retain original signed NAV exposures; leverage is not applied twice.
Normalized to 100% of analysed positions
Weights are normalized to 100% of absolute exposures across analysed positions, including positions outside this top list. Cash, collateral and unverified assets are excluded. Contributions retain original signed NAV exposures; leverage is not applied twice.
| # | Holding | Weight |
|---|---|---|
| 1 | Eli LillyLLY | 26.85% |
| 2 | Novo Nordisk A/SNVO | 21.47% |
| 3 | AbbVieABBV | 11.35% |
| 4 | RocheRO SW EQUITY | 8.44% |
| 5 | MerckMRK | 8.11% |
| 6 | NovartisNVS | 6.96% |
| 7 | AstraZenecaAZN | 5.83% |
| 8 | AmgenAMGN | 5.32% |
| 9 | PfizerPFE | 3.81% |
| 10 | Regeneron PharmaceuticalsREGN | 1.86% |
Holdings below 0.5% or outside the top list are folded into “Others” and omitted above.
Where the weight sits — sector mix
Listed equity weights summed by sector and normalized to 100%. Each band is one sector's share.
Industry breakdown
HHI sums the squared weights. The more it leans on a few names, the higher it goes — and the more the whole ETF moves with them.
How concentrated is it
Concentration (HHI) sits at 1577 — moderate. The top 10 names carry 100.0% of equity weight, so the fund is spread out but its largest holdings still steer it.
That is the usual shape of a cap-weighted index fund: broad, yet tilted toward the biggest companies.
HHI squares each weight and sums them: 10,000 means one stock is everything, and the more evenly spread the holdings, the closer it falls to zero.
Where the sector weight sits
By sector, Health Care alone is 92% — whatever the fund is called, this is a bet on that industry.
Bad news for the sector moves the whole fund. Worth checking against anything else you hold in the same space.
Weights above sum the individually listed equities and normalize that equity total to 100%.
How much it overlaps others
It shares 69% of its holdings with 476310 (6 names in common) — close to half the same companies.
Own both and the diversification is thinner than it looks.
What it is made of
The fund holds 11 positions in total; this page lists the largest 10 and folds the rest into "Others".
This page is not investment advice. Investment decisions and responsibility are your own.
476690 comments
Leave a one-line take on TIGER 글로벌비만치료제TOP2Plus. No account — just a nickname and a code to delete it later.
Loading…
Similar ETFs
Picked by how much their actual holdings overlap. The higher the overlap, the less diversification you get from owning both.